Search:

Clinical Trials & Medical Discoveries Headlines from PR Newswire


< Go Back

AbbVie Demonstrates Commitment to Continued Research in Hepatitis C with Investigational Data from Clinical Program Being Presented at The Liver Meeting®
Shionogi Inc. Announces Four Abstracts To Be Presented At The 25th Annual Meeting Of The North American Menopause Society (NAMS) In Washington, DC
Isis Pharmaceuticals Earns $1.5 Million From GSK for the Advancement of ISIS-GSK4 Rx
Ardelyx Reports Positive Results from Its Phase 2b Clinical Trial Evaluating Tenapanor in IBS-C Patients
Celebrate World Osteoporosis Day with Sunsweet
Northwestern Medicine Joins $20 Million National Uterine Fibroid Study
BioClinica Compass™ Wins Technology Innovation Award
PCORI, AHRQ Announce Research Team Selected to Compare Treatments for Uterine Fibroids
PCORI Board Approves $102 Million in Support for 46 New Research Projects
Small Denver Company Pharmatech driving a large revolution in how cancer clinical trials are managed
New Imaging Tool May Allow Tailoring of Stroke Prevention to Each Patient
DanDrit Biotech A/S Signs Agreement to Commence Clinical Trials of MelCancerVac®
CORD:USE is Pleased to Announce it has Partnered with Tianhe Stem Cell Biotechnologies, Developer of Cord Blood Stem Cell Therapy Showing Promising Results in Clinical Trials for the Treatment of Diabetes and Autoimmune Diseases
ELDOR Spinal Needle (CSEN International Ltd.) - The Perfect Needle for Spinal Anesthesia
Pittsburgh Business Leader Henry L. Hillman Provides $5 Million Gift for Carnegie Mellon's New BrainHub(SM) Initiative
Synapse Biomedical Announces the Early Completion of Enrollment in the FDA Post Approval Study for ALS Patients
KemPharm, Inc. Receives Patent from the USPTO for Novel Prodrug of Hydromorphone, KP511
GenSpera to Present Lead Drug Candidate Mipsagargin at 2nd Global Life Sciences Conference in Warsaw, Poland
LapSpace Nears Market Entry with Completion of FIM Surgical Procedures
Trelstar® Six-Month Dosing for Prostate Cancer Patients Launches in Canada
CytRx Initiates Global Phase 2b Clinical Trial of Aldoxorubicin for the Treatment of Relapsed/Refractory Small Cell Lung Cancer
De Gruyter Open Converts Eight Subscription Journals to Open Access megajournals
Regeneron and Sanofi Announce Positive Phase 2 Top-line Dupilumab Results in Patients with Chronic Sinusitis with Nasal Polyps
Institute Of Human Virology (IHV) Welcomes Renowned Infectious Disease Specialist Dr. Shyamasundaran Kottilil
HOPA Introduces First Investigational Drug Service Best Practice Standards For Institutions And Infusion Clinics
World Renowned Experts Discuss Future Of Cartilage Regeneration
Cancer Treatment Institute of Colombia Demonstrates Unprecedented Results Using Unique Cancer Drug Combination of 3-Bromopyruvate and Salinomycin for Treatment of Multiple Types of Cancer
Occlutech Obtains European CE Approval for its Dedicated Paravalvular Leak Closure Device
Frost & Sullivan Confers Technology Innovation Leadership Award on ADOCIA for its Robust Pipeline of Novel Therapeutic Proteins
Clinical Study Results of LifeBond's LifeSeal™ Surgical Sealant for GI Surgeries Announced at the ESCP's 9th Scientific & Annual Meeting
Arisaph Pharmaceuticals Awarded Supplemental Phase I And Phase II STTR Grants To Develop Oncology Drug Candidates
Manzo Pharmaceuticals announces successful results in laboratory tests of its lactose intolerance probiotic Lacto-Freedom
Galmed Pharmaceuticals and Itamar Medical to Collaborate on Assessing Aramchol's Effect on Endothelial Function
Aptose Biosciences Joins The Leukemia & Lymphoma Society's Groundbreaking Beat AML Research Initiative with Oregon Health & Science University
Trovagene Expands Clinical Program with New Study Evaluating its Precision Cancer Monitoring Platform in Lung Cancer
Genomic Health Announces Positive Results from Latest Clinical Validation Study of Oncotype DX® as Predictor of Near- and Long-term Outcomes in Racially Diverse Group of Prostate Cancer Patients
SALVAT Announces Positive Top-line Results from Two Phase III Studies of its Novel Otic Antibiotic/Steroid Combination Solution in the Treatment of AOMT with Tympanostomy Tubes
Phase 2 Trial Of Binimetinib In NRAS Melanoma Shows Promising Clinical Activity
Head-to-head Phase III trial demonstrates superior progression-free survival of afatinib compared to erlotinib in patients with advanced squamous cell carcinoma of the lung
GlySure Presents Successful Medical ICU Study Results at ESICM
Atox Bio Awarded Contract Worth up to $24 Million for the Development of AB103 by the Biomedical Advanced Research and Development Authority (BARDA)
Clinical Study Results of LifeBond's LifeSeal™ Surgical Sealant for GI Surgeries Announced at the ESCP's 9th Scientific & Annual Meeting
CytRx Receives Multiple FDA Orphan Drug Designations for Aldoxorubicin for the Treatment of Glioblastoma, Small Cell Lung Cancer and Ovarian Cancer English
CVRx® Receives CE Mark Approval of the Barostim neo System™ for the Treatment of Heart Failure Spanish
CHMP Announces Positive Opinion for REZOLSTA™, a New Once-Daily, Fixed-Dose HIV Therapy Combining Darunavir and Cobicistat
ZYTIGA® Plus Prednisone Demonstrates Statistically Significant Overall Survival After 49-Month Follow-Up Analysis in Chemotherapy-Naive Men with Metastatic Castration-Resistant Prostate Cancer
Novartis drug Afinitor® is first treatment for advanced pancreatic NET to provide overall survival of more than 3.5 years in Phase III trial
AbbVie Presents Results from Multiple Studies of Investigational Compound Veliparib in Patients with Non-Small Cell Lung Cancer at the European Society for Medical Oncology Annual Congress
Pivotal Phase III Trial Data for Anamorelin in ROMANA 1 and 2 Studies in Non-Small Cell Lung Cancer Patients with Anorexia-Cachexia Shows Significant Increase in Lean Body Mass, Body Weight and Improved Symptoms
Study Identifies Unexpected Clue to Peripheral Neuropathies

< Prev Next >
PR Newswire - United Business Media